Pheochromocytoma and paraganglioma
- PMID: 20541673
- PMCID: PMC4714594
- DOI: 10.1016/S0079-6123(10)82015-1
Pheochromocytoma and paraganglioma
Abstract
Pheochromocytoma is a very special kind of tumor full of duplicity. On the one hand it represents its own microworld with unique clinical, biochemical and pathological features, while on the other it constitutes a tremendously significant part of whole body system, playing a vital role for practically every organ system. It has a very special character - sometimes like a child it can be sweet and predictable, while at times it can behave like a deadly wild beast, crashing and tearing everything on its path in a fierce rage. It also consists of the amazingly intelligent neuroendocrine cells that possess a magical ability to make miraculous substances of many kinds. But most of all, it is a system that is able to drive our curiosity and the itch of "Cogito, ergo sum" to limitless depths and year by year it still amazes us with new and unexpected discoveries that move our understanding of multiple pathways and metabolic events closer to the ultimate truth. Recent discoveries of succinate dehydrogenase (SHD) and prolyl hydroxylase (PHD) mutations, for example, propelled our understanding of neuroendocrine tumorigenesis as a whole, as well as physiology of mitochondrial respiratory chain and phenomenon of pseudohypoxia in particular. Good old discoveries make their way from dusty repositories to shine with new meaning, appropriate for the current level of knowledge. This acquired wisdom makes us better physicians - knowing the specific expression makeup of catecholamine transporters, GLUTs and SRIFs allows for better tailored imaging and therapeutic manipulations. There are still long ways to go, keeping in mind that pheochromocytoma is but so very special, and we are optimistic and expect many great things to come.
Copyright 2010 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care.Horm Metab Res. 2012 May;44(5):325-7. doi: 10.1055/s-0031-1299759. Epub 2012 May 7. Horm Metab Res. 2012. PMID: 22566193 No abstract available.
-
Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.Pediatr Endocrinol Rev. 2017 Mar;14(3):312-325. doi: 10.17458/per.vol14.2017.RK.succinatedehydrogenase. Pediatr Endocrinol Rev. 2017. PMID: 28508602 Review. No abstract available.
-
Gene targeting through o-methylated catecholamine metabolite patterns.Clin Chem. 2011 Mar;57(3):361-2. doi: 10.1373/clinchem.2010.159178. Epub 2011 Jan 18. Clin Chem. 2011. PMID: 21245368 No abstract available.
-
Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.Cell Tissue Res. 2018 May;372(2):393-401. doi: 10.1007/s00441-018-2791-4. Epub 2018 Feb 15. Cell Tissue Res. 2018. PMID: 29450723 Free PMC article. Review.
-
Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.Front Endocrinol (Lausanne). 2021 Jan 29;11:610746. doi: 10.3389/fendo.2020.610746. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33584544 Free PMC article.
Cited by
-
Phaeochromocytoma: a catecholamine and oxidative stress disorder.Endocr Regul. 2011 Apr;45(2):65-90. doi: 10.4149/endo_2011_02_65. Endocr Regul. 2011. PMID: 21615192 Free PMC article.
-
A large pheochromocytoma requiring aortic and inferior vena caval reconstruction: A case report.Medicine (Baltimore). 2019 Jul;98(29):e16494. doi: 10.1097/MD.0000000000016494. Medicine (Baltimore). 2019. PMID: 31335714 Free PMC article.
-
Paraganglioma in pregnancy: A case series and literature review.Obstet Med. 2022 Mar;15(1):19-24. doi: 10.1177/1753495X211006012. Epub 2021 Apr 20. Obstet Med. 2022. PMID: 35444717 Free PMC article. Review.
-
11C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma.Cancers (Basel). 2019 Jun 19;11(6):847. doi: 10.3390/cancers11060847. Cancers (Basel). 2019. PMID: 31248124 Free PMC article.
-
Para-aortic haemangioma mimics paraganglioma on MRI.BMJ Case Rep. 2020 Dec 12;13(12):e235431. doi: 10.1136/bcr-2020-235431. BMJ Case Rep. 2020. PMID: 33310823 Free PMC article.
References
-
- Alezais H, Peyron A. Un groupe nouveau de tumeurs epitheliales: les paraganglions. Comptes Rendus des Séances et Mémoires de la Société de Biologie (Paris) 1908;65:745–747.
-
- Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. The Journal of Clinical Endocrinology & Metabolism. 2007;92:3822–3828. - PubMed
-
- Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-De Paillerets B, Chabre O, et al. Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology. 2005a;23:8812–8818. - PubMed
-
- Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. The Journal of Clinical Endocrinology & Metabolism. 2005b;90:2110–2116. - PubMed
-
- Andrew A, Kramer B, Rawdon BB. The origin of gut and pancreatic neuroendocrine (APUD) cells – the last word? Journal of Pathology. 1998;186:117–118. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials